NCT05821192 2023-04-20Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.The First Hospital of Jilin UniversityPhase NA Unknown34 enrolled